Acoustic Stimulation for Sleep Deprivation
Trial Summary
What is the purpose of this trial?
The purpose of this study is to determine if brief sounds or tones presented within a restricted period of recovery sleep after a period of sleep deprivation will enhance restorative properties and improve performance during a subsequent period of wakefulness.
Will I have to stop taking my current medications?
The trial does not specify if you must stop taking your current medications, but it mentions that certain medications may not be allowed on a case-by-case basis. It's best to discuss your specific medications with the trial coordinators.
What data supports the effectiveness of the treatment Philips SmartSleep Acoustic Stimulation Device for sleep deprivation?
Is acoustic stimulation for sleep generally safe for humans?
How does the Philips SmartSleep Acoustic Stimulation Device treatment differ from other treatments for sleep deprivation?
Eligibility Criteria
This trial is for healthy adults aged 18-39 who understand the study well (score at least 80% on a quiz), speak English as their first language, have a BMI below 30, sleep normally without disorders or irregularities, and don't use certain substances or medications. Pregnant women and regular smokers are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Sleep Deprivation
Participants undergo 40 hours of sleep deprivation
Recovery Sleep
Participants receive either acoustic stimulation or sham during a four-hour recovery sleep period over two nights
Follow-up
Participants are monitored for performance and mood using various tests and scales
Treatment Details
Interventions
- Philips SmartSleep Acoustic Stimulation Device
- Sham (no Acoustic Stimulation)
Philips SmartSleep Acoustic Stimulation Device is already approved in European Union, United States for the following indications:
- Sleep disorders
- Insomnia
- Circadian rhythm disorders
- Sleep disorders
- Insomnia
- Circadian rhythm disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
Walter Reed Army Institute of Research (WRAIR)
Lead Sponsor
Philips Healthcare
Industry Sponsor
Roy Jakobs
Philips Healthcare
Chief Executive Officer since 2022
Master's in Business Administration from Radboud University Nijmegen and Universitร degli Studi di Bologna
Dr. Roy Jakobs
Philips Healthcare
Chief Medical Officer
MD from McGill University